Gaoen Ma, MD
Hetian Lei Lab
Gaoen has ten years of clinical ophthalmological experience in China. His main focus was on treating outpatients and inpatient about proliferative vitreoretinopathy and proliferative diabetic retinopathy, and using vitrectomy to treat PVR and PDR.
His current work designs a therapeutic approach to proliferative vitreoretinopathy. He is testing the hypothesis that supression of PDGFRB using CRISPR/Cas9 technology will inhibit experimental proliferative vitreoretinopathy.
Skills/areas of expertise: Retina surgery.
Interests: Basketball and travel.
20 Staniford Street